Benzoyl peroxide
/ Benzoyl Peroxide, Acanya, Benzamycin, Benzoyl Peroxide /, Cabtreo, Duac, Epiduo, Epsolay, Onexton, Twyneo (benzoyl peroxide) is a small molecule pharmaceutical. Benzoyl peroxide was first approved as Benzamycin on 1984-10-26. It is used to treat acne vulgaris and rosacea in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| skin and connective tissue diseases | D017437 |
Trade Name
FDA
EMA
Epsolay
CombinationsAdapalene benzoyl peroxide, Benzamycin, Cabtreo, Clindamycin benzoyl peroxide, Duac, Epiduo, Erythromycin benzoyl peroxide, Onexton, Twyneo (discontinued: Adapalene benzoyl peroxide, Aktipak, Benzaclin, Clindamycin benzoyl peroxide, Erythromycin benzoyl peroxide)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Benzoyl peroxide
+
Clindamycin phosphate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ACANYA | Bausch Health Companies | N-050819 RX | 2008-10-23 | 1 products, RLD, RS |
| ONEXTON | Bausch Health Companies | N-050819 RX | 2014-11-24 | 1 products, RLD, RS |
| DUAC | Stiefel Laboratories | N-050741 RX | 2002-08-26 | 1 products, RLD |
Show 1 discontinued
Benzoyl peroxide
+
Erythromycin
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| BENZAMYCIN | Bausch Health Companies | N-050557 RX | 1984-10-26 | 1 products, RLD, RS |
Show 1 discontinued
Adapalene
+
Benzoyl peroxide
Benzoyl peroxide
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| EPSOLAY | Mayne Group | N-214510 RX | 2022-04-22 | 1 products, RLD, RS |
Benzoyl peroxide
+
Tretinoin
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TWYNEO | Mayne Group | N-214902 RX | 2021-07-26 | 1 products, RLD, RS |
Adapalene
+
Benzoyl peroxide
+
Clindamycin phosphate
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CABTREO | Bausch Health Companies | N-216632 RX | 2023-10-20 | 1 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| 10 acne med | C200263 | 2024-06-05 |
| 111 medco benzoyl peroxide | C200263 | 2023-12-12 |
| 2.5 acne med | C200263 | 2024-06-05 |
| 24 hour acne serum | C200263 | 2025-04-08 |
| 3 step acne system | OTC monograph final | 2018-02-22 |
| 30 day acne treatment kit | C200263 | 2024-11-04 |
| 5 acne med | C200263 | 2024-06-05 |
| 5 percent benzoyl peroxide cleanser | C200263 | 2023-11-10 |
| ab skincare acne spot treatment | OTC monograph final | 2018-09-27 |
| acanya | New Drug Application | 2020-09-30 |
Show 334 more
Indications
FDA
EMA
Show 16 more
Agency Specific
FDA
EMA
Expiration | Code | ||
|---|---|---|---|
BENZOYL PEROXIDE, EPSOLAY, GALDERMA LABS LP | |||
| 2025-04-22 | NP | ||
BENZOYL PEROXIDE / TRETINOIN, TWYNEO, GALDERMA LABS LP | |||
| 2024-07-26 | NC | ||
BENZOYL PEROXIDE / CLINDAMYCIN PHOSPHATE, CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, ENCUBE | |||
| 2023-03-13 | CGT | ||
Patent Expiration
Patent | Expires | Flag | FDA Information |
|---|---|---|---|
| Benzoyl Peroxide, Epsolay, Galderma Labs Lp | |||
| 11628155 | 2040-12-27 | U-3356 | |
| 11426378 | 2040-08-18 | U-3356 | |
| 10933046 | 2040-02-19 | DP | U-3357 |
| 10945987 | 2040-02-19 | U-3356 | |
| 11541026 | 2040-02-19 | U-3356 | |
| 9687465 | 2032-11-27 | DP | U-3356 |
| 9868103 | 2028-08-08 | DP | U-3194, U-3356 |
| Benzoyl Peroxide / Tretinoin, Twyneo, Galderma Labs Lp | |||
| 10420743 | 2038-07-12 | U-3194 | |
| 10653899 | 2030-12-30 | DP | U-3194 |
| 11071878 | 2030-12-30 | DP | |
| 8617580 | 2028-02-03 | DP | |
| Benzoyl Peroxide / Clindamycin Phosphate, Acanya, Bausch | |||
| 8288434 | 2029-08-05 | DP | U-124, U-134, U-818, U-916, U-921, U-1033 |
| 8663699 | 2029-06-03 | U-124 | |
| 8895070 | 2029-06-03 | U-124 | |
| 9078870 | 2029-06-03 | DP | |
| 9504704 | 2029-06-03 | DP | U-124, U-134, U-818, U-916 |
| 9561208 | 2029-06-03 | DP | U-916 |
| 10137142 | 2029-06-03 | DP | U-916 |
| 10220049 | 2029-06-03 | DP | U-916 |
| 10624918 | 2029-06-03 | U-916 | |
| Adapalene / Benzoyl Peroxide, Epiduo, Galderma Labs Lp | |||
| 8071644 | 2027-07-18 | DP | U-1078 |
| 8080537 | 2027-07-18 | U-1078 | |
| 8129362 | 2027-07-18 | U-1078 | |
| 8445543 | 2027-07-12 | U-1078 | |
| 7820186 | 2025-11-23 | DP | |
| 7964202 | 2024-09-01 | DP | U-1078 |
| Adapalene / Benzoyl Peroxide, Epiduo Forte, Galderma Labs | |||
| 8703820 | 2023-03-12 | U-1078 | |
| 8729127 | 2023-03-12 | U-1078 | |
| 9381179 | 2023-03-12 | U-1078 | |
| 9387187 | 2023-03-12 | U-1078 | |
HCPCS
No data
Clinical
Clinical Trials
6127 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Obesity | D009765 | EFO_0001073 | E66.9 | 7 | 5 | 8 | 13 | 164 | 196 |
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 13 | 7 | 15 | 17 | 134 | 182 |
| Acne vulgaris | D000152 | EFO_0003894 | L70 | 19 | 16 | 40 | 59 | 44 | 172 |
| Syndrome | D013577 | — | — | 10 | 35 | 25 | 11 | 96 | 169 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 8 | 4 | 14 | 15 | 84 | 125 |
| Stroke | D020521 | EFO_0000712 | I63.9 | 2 | 8 | 12 | 6 | 91 | 117 |
| Depression | D003863 | — | F33.9 | 6 | 2 | 6 | 3 | 85 | 102 |
| Hypertension | D006973 | EFO_0000537 | I10 | 2 | 7 | 13 | 12 | 68 | 101 |
| Cognitive dysfunction | D060825 | — | G31.84 | 3 | 10 | 5 | 7 | 78 | 101 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | 3 | 10 | 41 | 11 | 34 | 97 |
Show 456 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Exercise | D015444 | EFO_0000483 | — | — | 1 | 2 | — | 95 | 98 |
| Covid-19 | D000086382 | — | U07.1 | — | 10 | 9 | — | 46 | 64 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | 2 | — | 1 | — | 39 | 42 |
| Anxiety | D001007 | EFO_0005230 | F41.1 | 3 | 2 | 1 | — | 36 | 41 |
| Obstructive lung diseases | D008173 | — | — | — | 4 | 2 | — | 31 | 37 |
| Sleep initiation and maintenance disorders | D007319 | — | F51.01 | 2 | 2 | 3 | — | 28 | 35 |
| Inflammation | D007249 | MP_0001845 | — | 3 | 5 | 2 | — | 25 | 32 |
| Premature birth | D047928 | EFO_0003917 | O60 | 1 | 2 | 1 | — | 29 | 32 |
| Sarcopenia | D055948 | EFO_1000653 | M62.84 | — | — | 1 | — | 30 | 31 |
| Carcinoma | D002277 | — | C80.0 | 1 | 15 | 2 | — | 14 | 30 |
Show 294 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Aging | D000375 | GO_0007568 | R41.81 | 3 | 3 | — | — | 44 | 50 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | 2 | 2 | — | — | 36 | 40 |
| Neck pain | D019547 | — | M54.2 | — | 1 | — | — | 36 | 37 |
| Prediabetic state | D011236 | EFO_1001121 | R73.03 | 3 | 2 | — | — | 28 | 33 |
| Substance-related disorders | D019966 | EFO_0003890 | F13 | 4 | 4 | — | — | 20 | 27 |
| Sleep wake disorders | D012893 | — | G47 | 3 | 1 | — | — | 19 | 23 |
| Chronic disease | D002908 | — | — | — | 1 | — | — | 21 | 22 |
| Pediatric obesity | D063766 | — | — | — | 1 | — | — | 21 | 22 |
| Dental caries | D003731 | EFO_0003819 | K02 | — | 1 | — | — | 18 | 19 |
| Autistic disorder | D001321 | EFO_0003758 | F84.0 | 2 | 1 | — | — | 15 | 18 |
Show 290 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cerebral palsy | D002547 | — | G80 | 3 | — | — | — | 27 | 30 |
| Sleep | D012890 | GO_0030431 | — | 4 | — | — | — | 20 | 24 |
| Mental health | D008603 | EFO_0003935 | — | 1 | — | — | — | 10 | 11 |
| Healthy diet | D000072001 | — | — | 1 | — | — | — | 10 | 11 |
| Pain management | D059408 | — | — | 2 | — | — | — | 8 | 10 |
| Problem behavior | D000066553 | — | — | 1 | — | — | — | 9 | 10 |
| Laparoscopic cholecystectomy | D017081 | — | — | 2 | — | — | — | 7 | 9 |
| Oxygen inhalation therapy | D010102 | — | — | 1 | — | — | — | 8 | 9 |
| Respiration disorders | D012120 | — | J00-J99 | 1 | — | — | — | 7 | 8 |
| Bronchopulmonary dysplasia | D001997 | — | P27.8 | 1 | — | — | — | 6 | 7 |
Show 52 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sedentary behavior | D057185 | — | — | — | — | — | — | 52 | 52 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 41 | 41 |
| Chronic pain | D059350 | — | — | — | — | — | — | 27 | 27 |
| Emergencies | D004630 | — | — | — | — | — | — | 20 | 20 |
| Health behavior | D015438 | — | — | — | — | — | — | 20 | 20 |
| Weight gain | D015430 | — | — | — | — | — | — | 15 | 15 |
| Psychological stress | D013315 | — | — | — | — | — | — | 15 | 15 |
| Scoliosis | D012600 | EFO_0004273 | M41 | — | — | — | — | 14 | 14 |
| Disease progression | D018450 | — | — | — | — | — | — | 13 | 13 |
| Feeding behavior | D005247 | — | — | — | — | — | — | 13 | 13 |
Show 982 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Benzoyl peroxide |
| INN | — |
| Description | Benzoyl peroxide is a carbonyl compound. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | O=C(OOC(=O)c1ccccc1)c1ccccc1 |
Identifiers
| PDB | — |
| CAS-ID | 94-36-0 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1200370 |
| ChEBI ID | 82405 |
| PubChem CID | 7187 |
| DrugBank | DB09096 |
| UNII ID | — |
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Benzoyl peroxide
+
Adapalene
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Benzoyl peroxide
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Benzoyl peroxide
+
Clindamycin
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Benzoyl peroxide
+
Erythromycin
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Benzoyl peroxide
+
Hydrocortisone
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Benzoyl peroxide
+
Sulfur
Total medical expenditures per year (USD, in millions)
Mock data
Subscribe for the real data
Subscribe for the real data
Number of persons purchased
Mock data
Subscribe for the real data
Subscribe for the real data
Number of purchases
Mock data
Subscribe for the real data
Subscribe for the real data
Refill frequency
Mock data
Subscribe for the real data
Subscribe for the real data
Price per prescription (USD)
Mock data
Subscribe for the real data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 6,047 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
3,634 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use